Forbes Gives Its Four Tips For Raising Venture Capital In The Biotechnology Sector
Alexandro Pando writes that venture capitalists prefer tested and proven biotech enterprises, government- and NGO-backed funding remain ever so slightly out of reach, and every other funding outlet seemingly comes with its own set of hard-to-match requirements and specifications.
What is the fate of the budding startup without experience in the harsh economic climate of today’s biotech ecosphere? As it turns out, it's not quite as bad as one would expect. It’s all down to knowing the ropes and peculiarities of the market. To learn more about those four tips, read the full article.
Channel Your Fund Derivation Efforts In The Right Direction
Holding Off On VCs Can Sometimes Prove To Be Beneficial
Government Agencies Can Be A Viable Outlet, Too
New-Gen Funding Sources